JP2024506718A5 - - Google Patents
Info
- Publication number
- JP2024506718A5 JP2024506718A5 JP2023549616A JP2023549616A JP2024506718A5 JP 2024506718 A5 JP2024506718 A5 JP 2024506718A5 JP 2023549616 A JP2023549616 A JP 2023549616A JP 2023549616 A JP2023549616 A JP 2023549616A JP 2024506718 A5 JP2024506718 A5 JP 2024506718A5
- Authority
- JP
- Japan
- Prior art keywords
- aqueous solution
- composition according
- solution composition
- polypeptide
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2102258.7A GB202102258D0 (en) | 2021-02-17 | 2021-02-17 | Novel composition |
| GB2102258.7 | 2021-02-17 | ||
| PCT/US2022/016864 WO2022178175A1 (en) | 2021-02-17 | 2022-02-17 | Aqueous solution compositions for increasing stability of engineered dimeric proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506718A JP2024506718A (ja) | 2024-02-14 |
| JP2024506718A5 true JP2024506718A5 (cg-RX-API-DMAC10.html) | 2025-02-26 |
Family
ID=75338972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023549616A Pending JP2024506718A (ja) | 2021-02-17 | 2022-02-17 | 工学作成二量体タンパク質の安定性を高めるための水溶液組成物 |
Country Status (12)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023225513A1 (en) * | 2022-05-16 | 2023-11-23 | Inhibrx, Inc. | Effective dosage of recombinant serpin-fc fusion protein for use in a method of treating aat deficiency in a subject |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2476934C (en) * | 2002-02-27 | 2009-06-16 | Immunex Corporation | Stabilized tnfr-fc composition comprising arginine |
| AU2004216298B2 (en) * | 2003-02-28 | 2009-04-23 | Chugai Seiyaku Kabushiki Kaisha | Stabilized protein-containing formulations |
| PT1684719E (pt) * | 2003-11-14 | 2012-02-03 | Baxter Int | Composições de alfa-1-antitripsina e métodos de tratamento utilizando estas composições |
| JP4965446B2 (ja) * | 2004-08-31 | 2012-07-04 | ノヴォ ノルディスク アー／エス | ペプチド、ポリペプチド及びタンパク質の安定化のためのトリス（ヒドロキシメチル）アミノメタンの使用 |
| JP2008543839A (ja) * | 2005-06-14 | 2008-12-04 | アムジェン インコーポレーテッド | 自己緩衝タンパク質製剤 |
| KR20080071192A (ko) * | 2005-11-22 | 2008-08-01 | 와이어쓰 | 면역글로불린 융합 단백질 제형 |
| GB0700523D0 (en) * | 2007-01-11 | 2007-02-21 | Insense Ltd | The Stabilisation Of Proteins |
| EP2598167B1 (en) * | 2010-07-30 | 2015-04-01 | Arecor Limited | Stabilized aqueous antibody compositions |
| BR112013025845A2 (pt) * | 2011-04-07 | 2018-09-04 | Glaxosmithkline Llc | formulações com viscosidade reduzida |
| SMT201900520T1 (it) | 2011-06-28 | 2019-11-13 | Inhibrx Lp | Polipeptidi di fusione serpinici e relativi metodi d'uso |
| KR20140137347A (ko) * | 2012-01-10 | 2014-12-02 | 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 | 알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도 |
| US9527890B2 (en) * | 2013-06-18 | 2016-12-27 | The Brigham And Womens's Hospital, Inc. | FC receptor (FcRn) binding peptides and uses thereof |
| CN110903398B (zh) * | 2014-01-15 | 2023-08-15 | 豪夫迈·罗氏有限公司 | 具有修饰的FCRN和保持的蛋白A结合性质的Fc区变体 |
| US20170190762A1 (en) * | 2014-06-11 | 2017-07-06 | Beth Israel Deaconess Medical Center, Inc. | Alpha1 -antitrypsin compositions and methods of treating autoimmune diseases |
| MX2017005467A (es) * | 2014-10-27 | 2017-11-30 | Inhibrx Lp | Polipéptidos de fusión de serpina y métodos para utilizar los mismos. |
| GB201703063D0 (en) * | 2017-02-24 | 2017-04-12 | Arecor Ltd | Stabilized antibody protein solutions |
| GB201721846D0 (en) * | 2017-12-22 | 2018-02-07 | Arecor Ltd | Novel composition |
-
2021
- 2021-02-17 GB GBGB2102258.7A patent/GB202102258D0/en not_active Ceased
-
2022
- 2022-02-17 AU AU2022224607A patent/AU2022224607A1/en active Pending
- 2022-02-17 EP EP22709101.4A patent/EP4294372A1/en active Pending
- 2022-02-17 CN CN202280028860.9A patent/CN117279624A/zh active Pending
- 2022-02-17 JP JP2023549616A patent/JP2024506718A/ja active Pending
- 2022-02-17 IL IL305142A patent/IL305142A/en unknown
- 2022-02-17 BR BR112023016442A patent/BR112023016442A2/pt unknown
- 2022-02-17 KR KR1020237031527A patent/KR20230147140A/ko active Pending
- 2022-02-17 MX MX2023009630A patent/MX2023009630A/es unknown
- 2022-02-17 WO PCT/US2022/016864 patent/WO2022178175A1/en not_active Ceased
- 2022-02-17 US US17/674,713 patent/US20220265788A1/en not_active Abandoned
- 2022-02-17 CA CA3208704A patent/CA3208704A1/en active Pending
-
2024
- 2024-09-30 US US18/902,711 patent/US20250177501A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10772963B2 (en) | Etanercept formulations stabilized with xylitol | |
| US20210007991A1 (en) | Etanercept formulations exhibiting marked reduction in sub-visible particles | |
| TWI515006B (zh) | 重組ｖｗｆ調配物 | |
| JP2005348744A (ja) | 組織因子活性インヒビターの産生 | |
| JP6030201B2 (ja) | α‐１プロテイナーゼインヒビターのための組成物、方法およびキット | |
| JP2007511539A (ja) | α１−抗トリプシン組成物およびこのような組成物を用いた処置方法 | |
| AU2004288854B2 (en) | Dry recombinant human alpha 1-antitrypsin formulation | |
| KR100330540B1 (ko) | 안티트롬빈-iii액상제제및그안정화방법 | |
| JP2024506718A (ja) | 工学作成二量体タンパク質の安定性を高めるための水溶液組成物 | |
| JPWO1994022471A1 (ja) | アンチトロンビン−３液状製剤およびその安定化方法 | |
| JP2022544216A5 (cg-RX-API-DMAC10.html) | ||
| JP2722143B2 (ja) | トリプシンインヒビター含有凍結乾燥製剤 | |
| JP2660484B2 (ja) | ヒト尿性トリプシンインヒビター含有液状製剤 | |
| JP2025518537A (ja) | 対象のＡＡＴ欠損症を治療する方法に使用するための有効量の組換えセルピン－Ｆｃ融合タンパク質 | |
| JPH0625011A (ja) | ヒト尿性トリプシンインヒビター含有液状製剤及びその製造方法 | |
| JP2024507347A (ja) | Ｆｃドメインを含む操作されたタンパク質コンストラクトの水性組成物 | |
| HK1200851B (en) | Etanercept formulations stabilized with amino acids | |
| HK1200720B (en) | Etanercept formulations stabilized with combinations of sugars and polyols | |
| HK1200719B (en) | Etanercept formulations stabilized with metal ions |